pHIV-iRFP720-E2A-Luc Citations (3)
Originally described in: Multimodal cell tracking from systemic administration to tumour growth by combining gold nanorods and reporter genes.Comenge J, Sharkey J, Fragueiro O, Wilm B, Brust M, Murray P, Levy R, Plagge A Elife. 2018 Jun 27;7. pii: 33140. doi: 10.7554/eLife.33140. PubMed Journal
Articles Citing pHIV-iRFP720-E2A-Luc
| Articles |
|---|
CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models.
Timpanaro A, Piccand C, Dzhumashev D, Anton-Joseph S, Robbi A, Moser J, Rossler J, Bernasconi M.
J Exp Clin Cancer Res. 2023 Nov 4;42(1):293. doi: 10.1186/s13046-023-02838-3.
PubMed
Associated Plasmids |
| Constitutive activation of the Src-family kinases Fgr and Hck enhances the tumor burden of acute myeloid leukemia cells in immunocompromised mice. Shu ST, Chen L, Gonzalez-Areizaga G, Smithgall TE. Sci Rep. 2025 Jan 2;15(1):174. doi: 10.1038/s41598-024-83740-6. PubMed |
| Enhanced bioluminescence imaging of tumor cells surviving chemotherapy in a murine model of triple-negative breast cancer. Steinbauer S, Cowles JD, Sabbaghi MA, Poppelaars M, Hussain A, Wagesreither M, Laimer-Gruber D, Tovari J, Szakacs G, Csiszar A. NPJ Breast Cancer. 2025 Jul 30;11(1):80. doi: 10.1038/s41523-025-00795-y. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.